Loading clinical trials...
Loading clinical trials...
The purpose of this study is to assess the safety of intravenous (IV) cocaine in subjects taking quetiapine at 3 dosage levels.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
National Institute on Drug Abuse (NIDA)
NCT04155632 · Cocaine-Related Disorders
NCT02773212 · Cocaine-Related Disorders, Anhedonia
NCT03986762 · Cocaine Dependence, in Remission, Cocaine Abuse, in Remission, and more
NCT03606473 · Cocaine-Related Disorders
NCT00000276 · Cocaine-Related Disorders
Boston University Medical Center
Boston, Massachusetts
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions